Exploring Rare Gynecologic Tumors: A Cutting-Edge Perspective on Modern Diagnostic and Therapeutic Strategies
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Gynecologic Oncology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 122
Special Issue Editors
Interests: gynecological tumors; genito-urinary tumors; immunotherapy; PARPis; meta-analysis; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: cervical cancer; ovarian cancer; endometrial cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The classification of gynecological tumors has changed in recent years, and various rare variants of the disease have been described or re-classified. At the same time, pathological and radiological criteria for their diagnosis, molecular profiling, and subsequent clinical treatment modalities have been widely developed.
This Special Issue aims to give readers (gynecologists, oncologists, pathologists, radiologists, and radiotherapists) a clear picture of the new landscape of rare gynecological tumors. It will focus on modern techniques for differential diagnoses and the appropriate clinical management of several diseases that, due to their rarity, are almost forgotten about in the medical literature, aiming to increase the body of knowledge on these tumors.
This Special Issue will accept systematic and narrative reviews, original articles, case reports, and all other types of scientific papers.
I look forward to receiving your contributions.
Dr. Brigida Anna Maiorano
Dr. Vera Loizzi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vulvar cancer
- rare gynecological tumor
- Paget disease
- uterine sarcoma
- vaginal cancer
- ovarian cancer
- rare gynecological cancer
- small cell carcinoma genital tract
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
